Clinical Trial Update: Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating dietary modification of the microbiome–metabolomic axis to mitigate graft-versus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Hematopoietic Stem Cell Transplantation | Phase 2 | Status: COMPLETED